VIRUS - VACCINE RESEARCH - AP 4-9-2020 2.jpeg
- Updated
In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a pharmacy technologist using a biosafety level 2 hood prepares a COVID-19 coronavirus vaccine candidate for testing in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)
As featured on
The treatment is monoclonal antibody therapy, and the antibodies come from people who have recovered from the novel coronavirus. Researchers then take the blood, select the most potent antibodies, and make them into a drug.